Armata Pharmaceuticals, Inc. (ARMP) › EBITDAArmata Pharmaceuticals, Inc. (ARMP): EBITDAOperating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.-$41.11MYear ended 2024-12-312022-12-31: -$36.05M2023-12-31: -$39.92M2024-12-31: -$41.11M-$41.11M2022-12-31 EBITDA (USD) 2024-12-31Period endedEBITDAChange YoYSource filing2024-12-31-$41.11Mn/m2026-03-25, From 2024-01-012023-12-31-$39.92Mn/m2025-03-21, From 2023-01-012022-12-31-$36.05Mn/a2024-03-21, From 2022-01-01Other metrics: R&D ExpenseOperating IncomeDepreciation & AmortizationNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowDividends PaidShares OutstandingWeighted Average Diluted SharesEPS (Basic)